Company intelligence / Profile preview

Amador Bioscience

Pleasanton, California, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

As a full-service global CRO founded in 2018, Amador Bioscience offers translational science, clinical pharmacology, bioanalysis & biomarkers, regulatory strategy & submission services. It has supported over 80 clinical projects and multiple IND/CTD filings in the US and China. The company does not develop its own drugs but enables biopharma clients to advance their pipelines efficiently through expert-driven support across all phases of drug development.

Modalities: Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugate
Industry: Contract Research Organization

Beyond the preview

Go deeper on Amador Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amador Bioscience.

Explore the full profile